Galletta Christopher 4
4 · Trevi Therapeutics, Inc. · Filed Feb 16, 2024
Insider Transaction Report
Form 4
Galletta Christopher
See Remarks
Transactions
- Award
Stock Option (right to buy)
2024-02-15+28,500→ 28,500 totalExercise: $2.38Exp: 2034-02-14→ Common Stock (28,500 underlying)
Footnotes (1)
- [F1]This option was granted on February 15, 2024. The 28,500 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 15, 2025 and as to the remaining 75% of the shares in equal monthly installments thereafter through February 15, 2028.